Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Fractalkine in rheumatoid arthritis: a review to date Murphy G; Caplice N; Molloy MRheumatology (Oxford) 2008[Oct]; 47 (10): 1446-51Rheumatoid arthritis (RA) is characterized by the expansion of the synovium, with infiltration of pro-inflammatory cells, neovascularization and an abundance of pro-inflammatory cytokines resulting in tissue destruction and bone erosion. Fractalkine (FKN), a recently described chemokine, possesses chemotactic, angiogenic and adhesive functions that associates it with all of these destructive processes. In this review, we describe the research to date, which implicates FKN and its receptor in the pathogenesis of RA and propose that this molecule may represent a future therapeutic target for RA.|Antirheumatic Agents/therapeutic use[MESH]|Arthritis, Rheumatoid/drug therapy/*physiopathology[MESH]|Chemokine CX3CL1/antagonists & inhibitors/*physiology[MESH]|Chemotaxis, Leukocyte[MESH]|Humans[MESH]|Neovascularization, Pathologic/physiopathology[MESH]|Synovial Membrane/blood supply/pathology[MESH] |